Cardiac hypertrophy was also developed in Ang II-infused hearts compared to control hearts, as indicated by increases in heart weight to body weight ratios (Figure 1C) and ANF mRNA expression in myocytes (Figure 1D). The gene discussed is NPPA; the disease is cardiac hypertrophy.